You are here

  • Home
  • Archive
  • Volume 11, Issue 1
  • Use of tyrosine kinase inhibitors for paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia: a systematic review and meta-analysis

Article metrics

Article menu
XML
Evidence based practice
Original research
Use of tyrosine kinase inhibitors for paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia: a systematic review and meta-analysis

 

Online download statistics by month:

Online download statistics by month: January 2021 to September 2024

AbstractFullPdf
Jan 202116916575
Feb 202114814369
Mar 2021696436
Apr 2021757241
May 2021928733
Jun 20211029647
Jul 2021716943
Aug 2021969733
Sep 2021716626
Oct 2021736644
Nov 2021302736
Dec 2021796646
Jan 2022434828
Feb 2022505234
Mar 2022636325
Apr 2022393817
May 2022777233
Jun 2022717229
Jul 2022505222
Aug 2022474218
Sep 2022636056
Oct 2022252712
Nov 2022504813
Dec 2022555616
Jan 2023545521
Feb 2023414316
Mar 2023807020
Apr 2023444322
May 2023343014
Jun 2023383722
Jul 2023504719
Aug 2023343110
Sep 202333316
Oct 2023555317
Nov 2023394012
Dec 2023612817
Jan 2024262111
Feb 20249912
Mar 2024363458
Apr 2024554630
May 2024514325
Jun 2024413220
Jul 2024414021
Aug 2024393118
Sep 2024987
Total257824201230